Kodiak Sciences, Inc. (KOD)
81.09
-10.54
(-11.50%)
USD |
NASDAQ |
Oct 14, 16:00
82.75
+1.66
(+2.05%)
Pre-Market: 09:06
Kodiak Sciences Total Long Term Debt (Quarterly) : 142.94M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 142.94M |
| March 31, 2026 | 144.33M |
| December 31, 2025 | 147.12M |
| September 30, 2025 | 150.45M |
| June 30, 2025 | 153.92M |
| March 31, 2025 | 156.69M |
| December 31, 2024 | 159.72M |
| September 30, 2024 | 163.24M |
| June 30, 2024 | 165.87M |
| March 31, 2024 | 168.72M |
| December 31, 2023 | 171.86M |
| September 30, 2023 | 174.46M |
| June 30, 2023 | 176.94M |
| March 31, 2023 | 178.81M |
| December 31, 2022 | 177.80M |
| September 30, 2022 | 178.68M |
| June 30, 2022 | 180.95M |
| March 31, 2022 | 176.37M |
| Date | Value |
|---|---|
| December 31, 2021 | 176.01M |
| September 30, 2021 | 177.27M |
| June 30, 2021 | 176.92M |
| March 31, 2021 | 75.85M |
| December 31, 2020 | 75.03M |
| September 30, 2020 | 76.31M |
| June 30, 2020 | 1.263M |
| March 31, 2020 | 1.383M |
| December 31, 2019 | 1.501M |
| September 30, 2019 | 1.616M |
| June 30, 2019 | 1.725M |
| March 31, 2019 | 1.882M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 46.48M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 11.61M |
| September 30, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.707B |
| AbbVie, Inc. | 70.82B |
| Mirum Pharmaceuticals, Inc. | 760.54M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |